These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7220429)

  • 1. Pancreatic oncofoetal antigen in pancreatic cancer.
    Hobbs JR; Branfoot AC; Knapp ML
    Practitioner; 1980 Oct; 224(1348):1023-7. PubMed ID: 7220429
    [No Abstract]   [Full Text] [Related]  

  • 2. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigens in the blood serum in pancreatic cancer].
    Vel'bri SK
    Vopr Onkol; 1979; 25(11):28-31. PubMed ID: 516561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma.
    Loor R; Kuriyama M; Bodziak ML; Inaji H; Douglass HO; Berjian R; Nicolai JJ; Tytgat GN; Chu TM
    Cancer Res; 1984 Aug; 44(8):3604-7. PubMed ID: 6744282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma].
    Nouts A; Lévy P; Voitot H; Bernades P
    Gastroenterol Clin Biol; 1998 Feb; 22(2):152-9. PubMed ID: 9762189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody-defined human pancreatic cancer-associated antigens.
    Schmiegel WH; Kalthoff H; Arndt R; Gieseking J; Greten H; Klöppel G; Kreiker C; Ladak A; Lampe V; Ulrich S
    Cancer Res; 1985 Mar; 45(3):1402-7. PubMed ID: 3882225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
    Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
    Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic significance of pancreatic antigen determination].
    Velbri S; Männiste J
    Z Gesamte Inn Med; 1980 Sep; 35(17):684-8. PubMed ID: 6162288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CA 19-9 and cancer of the pancreas. Critical review of the literature].
    Delcourt A
    Acta Gastroenterol Belg; 1987; 50(1):1-8. PubMed ID: 3321822
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic markers of pancreatic cancer in humans].
    Kulagin PP; Chalov VV
    Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic oncofoetal antigen (POA): its frequency and localisation in humans.
    Hobbs JR; Knapp ML; Branfoot AC
    Oncodev Biol Med; 1980 Aug; 1(1):37-48. PubMed ID: 7279697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention to CA 19.9 in alcoholics. Apropos of a case].
    Giovannini M; Penalvert F; Maillot A; Escoffier JM; Botta D; Gauthier A
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):393. PubMed ID: 3481241
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-associated antigen in human pancreatic cancer.
    Schultz DR; Yunis AA
    J Natl Cancer Inst; 1979 Apr; 62(4):777-85. PubMed ID: 85737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biohumeral markers in the diagnosis of pancreatic carcinoma].
    Panucci A; Del Favero G; Falmis C; Brosolo P; Basso D; Pedrazzoli S; Baccaglini U; Marchioro L; Bonvilini P; Naccarato R
    Recenti Prog Med; 1985; 76(7-8):385-91. PubMed ID: 3865269
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.
    Lee SS; Byun JH; Park BJ; Park SH; Kim N; Park B; Kim JK; Lee MG
    J Magn Reson Imaging; 2008 Oct; 28(4):928-36. PubMed ID: 18821618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer.
    Loor R; Nowak NJ; Manzo ML; Douglass HO; Chu TM
    Clin Lab Med; 1982 Sep; 2(3):567-78. PubMed ID: 6754226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of a serum pancreatic tumor marker: the carbohydrate antigen C.A. 19-9].
    Vincent D; Venot J; Catanzano G; Clément MN; Piquet MF; Veyriras E; Beck C
    Ann Med Interne (Paris); 1985; 136(2):142-4. PubMed ID: 3865571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.